| Bioactivity | (Thr(GalNAc)4,7,15,Ser(GalNAc)9,11)-IgA1 Hinge Region Peptide (TFA) (GN5) is a synthetic glycopeptide and can be used for detection of gender difference and epitope specificity of IgG antibody activity against IgA1 hinge portion in IgA nephropathy patients[1]. |
| Name | (Thr(GalNAc)4,7,15,Ser(GalNAc)9,11)-IgA1 Hinge Region Peptide TFA |
| Sequence | Val-Pro-Ser-{Thr-GalNAc}-Pro-Pro-{Thr-GalNAc}-Pro-{Ser-GalNAc}-Pro-{Ser-GalNAc}-Thr-Pro-Pro-{Thr-GalNAc}-Pro-Ser-Pro-Ser |
| Shortening | VPS-{Thr-GalNAc}-PP-{Thr-GalNAc}-P-{Ser-GalNAc}-P-{Ser-GalNAc}-TPP-{Thr-GalNAc}-PSPS |
| Formula | C121H193N25O53.xC2HF3O2 |
| Molar Mass | 2845.96 (free acid) |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Nakamura I, et al. Detection of gender difference and epitope specificity of IgG antibody activity against IgA1 hinge portion in IgA nephropathy patients by using synthetic hinge peptide and glycopeptide probes. Nephrology (Carlton). 2004;9(1):26-30. |
(Thr(GalNAc)4,7,15,Ser(GalNAc)9,11)-IgA1 Hinge Region Peptide TFA
CAS: F: C121H193N25O53.xC2HF3O2 W: 2845.96 (free acid)
(Thr(GalNAc)4,7,15,Ser(GalNAc)9,11)-IgA1 Hinge Region Peptide (TFA) (GN5) is a synthetic glycopeptide and can be used fo
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.